Related Experiment Videos

Alterations in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats

R R Dalvi1

  • 1Toxicology Laboratory, School of Veterinary Medicine, Tuskegee University, AL 36088.

Toxicology Letters
|May 1, 1992
PubMed

Insights

Garlic oil

Area of Science:

  • Pharmacology and Toxicology
  • Drug Metabolism Studies

Background:

  • Garlic oil, containing diallyl sulfide, is known for its biological activities.
  • Understanding its impact on drug metabolism is crucial for safety and efficacy assessments.

Purpose of the Study:

  • To investigate the dose-dependent effects of garlic oil on Phase I and Phase II biotransformation enzymes in rats.
  • To determine if garlic oil administration causes liver damage.

Main Methods:

  • Adult male Sprague-Dawley rats were administered single or repeated doses of garlic oil (500 mg/kg i.p. or 50 mg/kg i.p. for 5 days).
  • Hepatic microsomal and cytosolic enzymes, including cytochrome P-450, were measured.
  • Serum enzyme tests were used to assess liver damage.

Main Results:

  • A single high dose of garlic oil (500 mg/kg) depressed hepatic cytochrome P-450 and related enzymes.
  • Repeated low-dose administration (50 mg/kg) significantly increased cytochrome P-450 and other enzyme activities.
  • No evidence of liver damage was observed.

Conclusions:

  • Garlic oil exhibits dose-dependent effects on hepatic drug-metabolizing enzymes.
  • Low-dose, repeated exposure to garlic oil can induce key drug-metabolizing enzymes.
  • Garlic oil does not appear to cause liver toxicity at the tested doses.

Related Concept Videos